With reference to the earlier announcement dated April 30, 2012, Akzo Nobel India Ltd has informed BSE that the Company have received copies of all the court orders and necessary filings have been done on May 18, 2012. Accordingly, the merger of Akzo Nobel Car Refinishes India Private Limited, Akzo Nobel Coatings India Private Limited and Akzo Nobel Chemicals (India) Limited with Akzo Nobel India Limited has become effective.

& Audited Results to consider the following: 1. To alter object clause of the memorandum of association and 2. Resignation letter received from Shri N.D.Rana as Managing Director.

B&A Packaging India Ltd has informed BSE that Mr. Rajiv Gupta has been appointed for the post of Company Secretary w.e.f. May 08, 2012 by Circular Resolution Dated May 08, 2012. Further the Company has informed that, Mr. Rajiv Gupta will also act as the Compliance Officer of the Company till the time he remains Company Secretary of the Company.

Audited Results & inter alia, to consider the following: - The Audited Financial Results of the Company for the year ended March 31, 2012. - To consider and approve resignation of Mr. K. Srinivasa Varadhan as a Director.

Chettinad Cement Corporation Ltd has informed BSE that that Mr. L. Muthukrishnan, Chartered Accountant has been Co-opted on the Board of the Company as an Additional Director with effect from May 15, 2012.

With reference to the earlier announcement regarding Sale of Shares, Deepak Nitrite Ltd has now informed BSE that the Company has sold equity shares held in Yerrowda Investments Limited (YIL) in terms of which the Company had permanent rights of occupation in specified properties belonging to YIL. The profit on sale of these shares is about Rs. 850 lacs which will be reflected in the interim financial statements for the quarter ending June 30, 2012.

Dr Reddys Laboratories Ltd has informed BSE regarding a press release dated May 18, 2012, titled "Dr. Reddy's announces the Launch of Clopidogrel Tablets, USP". Prees Release: "Dr. Reddy's Laboratories announced today that it has launched CLOPIDOGREL TABLETS, USP 75 mg & 300 mg, a bioequivalent generic version of PLAViX in the US market on May 18 , 2012. The ANDAs for Clopidogrel Tablets USP, 75 mg & 300 mg are approved by the United States Food & Drug Administration (USFDA). Dr. Reddy's Laboratories was among the first applicants to submit a substantially complete ANDA for Clopidogrel Tablets USP, 300 mg with a Paragraph IV certification, and was awarded 180 days of marketing exclusivity for this strength." (For more details kindly refer Corporate Announcements on www.bseindia.com).

inter alia; 1. Recommended the Dividend of Rs. 17.50/- per equity share of Rs. 10/- each for the year 2011- 12. The dividend, if approved by shareholders at the ensuing Annual General Meeting, will be paid on/after August 28, 2012. 2. Approved appointment of Mr. Alok Goyal as an Additional Director on Board of the Company, with effect from May 18, 2012. Mr. Goyal joins the Board as a Non Executive Independent Director. The Board of Directors also reconstituted remuneration Committee(s) to include Mr. Goyal as member of the said Committee(s). 3. Resolved to convene the Twelfth Annual General Meeting on August 23, 2012.

Essar Shipping Ltd has informed BSE that the Compensation Committee of the Board of Directors of the Company at its Meeting held on May 17, 2012, approved 4,03,549 Stock Options Lapsed during the Quarter Ended March 31, 2012.

HB Stockholdings Ltd has informed BSE that Hon'ble Securities Appellate Tribunal vide its Order dated May 17, 2012, has stayed the operation of the above mentioned SEBI order dated May 09, 2012 till the disposal of the Appeal filed by the Company in the said matter. Further to that, the Honble Securities Appellate Tribunal has also fixed July 11, 2012 for final hearing of the Appeal.

Housing Development Finance Corporation Ltd has informed BSE that the Corporation on May 18, 2012 allotted 1,79,440 equity shares of Rs. 2 each pursuant to exercise of stock options by certain employees/directors and 9,250 equity shares of Rs. 2 each of the Corporation under pursuant to exchange of 9,250 Warrants. Further, the Corporation has extinguished the said 9,250 Warrants and the outstanding Warrants post the said exchange stands at 5,46,95,580. Post the above allotment, the paid-up equity share capital of the Corporation would stand at Rs. 295,43,25,000 consisting of 147,71,62,500 equity shares of Rs. 2 each.

Helios and Matheson Information Technology Ltd has informed BSE that a Meeting of the Allotment Committee of the Board of Directors of the Company will be held on May 23, 2012, to consider allotment of 25 lakh nos of convertible warrants on preferential basis to the promoters in terms of the approval given by the members of the Company at the annual general meeting held on March 29, 2012.

Hikal Ltd has informed BSE that Honble High Court of Judicature at Bombay has approved the Scheme of Arrangement between Acoris Research Limited (Acoris) and Hikal Limited (Hikal or the Company) and their respective shareholders and creditors for demerger of Research Business Undertaking of Acoris (a wholly owned subsidiary of Hikal) vide Order dated March 30, 2012, certified copy of which was made available on May 02, 2012. Certified copy of the order as referred above, Sanctioning the scheme from April 01, 2012, being the appointed date has been filed electronically with the Registrar of Companies, Maharashtra, Mumbai on May 10, 2012. Thus, the scheme has become effective from May 10, 2012. Accordingly, Research Business Undertaking of Acoris has been demerged with Hikal Ltd.

inter alia, resolved the following: 1. Recommended the payment of dividend on Equity shares @ Re. 1/- (Rupee One only) per share i.e. 10% of the paid up Equity Share Capital of Company for the year ended March 31, 2012 subject to approval of the shareholders in the forthcoming Annual General Meeting of the Company. 2. Taken on record resignation of Lt. Gen. K. S. Brar w.e.f. May 18, 2012.

With reference to the earlier announcement dated January 10, 2012 regarding the in principle approval granted by the Boards of the respective Companies for amalgamation of the step down subsidiaries of JM Financial Ltd (the Company) with JM Financial Consultants Private Limited, a wholly owned subsidiary of the Company, JM Financial Ltd has now informed BSE that the Honble High Court of Judicature at Bombay, vide its order dated April 27, 2012, has sanctioned the Scheme of Arrangement for amalgamation of JM Financial Institutional Securities Private Limited, JM Financial Securities Private Limited and JM Financial Ventures Limited along with its four subsidiaries viz: Oracle Enterprises Private Limited, Latitude Mercantile Private Limited, Ardour Trading Private Limited and Saptarishi Sales & Trading Private Limited with JM Financial Consultants Private Limited.

inter alia, approved the following: 1. Recommended dividend of Rs. 2/- (i.e. 20%) per equity share of Rs. 10/- each on 2,61,18,348 Equity Shares for the financial year 2011-12, subject to approval of members. 2. Mr. S. K. Tripathi, Executive Director of the Company has been re-designated as Dy. Managing Director w.e.f. May 18, 2012. 3. The Company has appointed Mr. Manoj Kumar Singh, as Executive Director w.e.f. May 18, 2012. 4. Mr. Ramesh Sheth, Non-Executive Director of the company has resigned w.e.f. May 18, 2012.

JSW ISPAT Steel Ltd has informed BSE that the Securities Issue Committee of Board of Directors of the Company, at its meeting held on May 18, 2012, has allotted an aggregate of 13,00,31,371 Equity Shares of Rs. 10/- each in the Company, on preferential basis, at a premium of Rs. 4.74 per share, to the CDR Lenders of the Company. The aforesaid equity shares have been allotted to the respective lenders upon their opting to convert a part of their outstanding Working Capital Term Loan (WCTL)/Funded Interest Term Loan (FITL)/Rupee Term Loan (RIL) into equity shares, in terms of the approval granted by CDR Empowered Group. The aforesaid equity shares shall rank pari-passu interse with the existing equity shares of the Company in all respect, including dividend.

Kirloskar Industries Ltd has informed BSE that Mr. Vikram S. Kirloskar, Director of the Company ceased to be a Director with effect from May 18, 2012.

Mindteck (India) Ltd has informed BSE that Mr. Vivek Malhotra, Director of the Company has resigned from his position as member of the Board of Directors with effect from May 09, 2012, and the same has been approved by the Board of Directors of the Company.

MSP Steel & Power Ltd has informed BSE that in accordance with the directions of the Hon'ble High court of Judicature at Calcutta in Company Application No. 62 of 2012, the meeting of the equity shareholders of the Company was convened and held at Rotary Sadan 94/2, Chowringhee Road, Kolkata-700 020 on May 17, 2012 at 11:30 A.M. and, the equity shareholders have approved the Scheme with requisite majority.